Health and Healthcare

Gilead Sciences : GILD

All Gilead Sciences Articles

732 Articles

Chris Lange | Sep 12, 2019 at 8:40 AM EDT

Major Biotechs Scare Off Short Sellers

The August 30 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Aug 27, 2019 at 9:15 AM EDT

Short Sellers Hike Their Bets in Biotech

The August 15 short interest data has been compared with the previous report, and short interest in most of these…

Jon C. Ogg | Aug 26, 2019 at 10:25 AM EDT

30 Sustainable Dividend Yields of 3.5% to Over 5% for Cautious Income Investors

Here are 30 stocks with sustainable dividends for income investors to consider in their portfolios.

Jon C. Ogg | Aug 12, 2019 at 12:10 PM EDT

Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead

24/7 Wall St. has evaluated all pharmaceutical and biotech companies that pay dividend yields above 2% based on their current…

Chris Lange | Aug 12, 2019 at 8:50 AM EDT

Short Sellers Make a Move on Big Biotechs

The July 31 short interest data has been compared with the previous report, and short interest in most of these…

Jon C. Ogg | Jul 31, 2019 at 9:03 AM EDT

Top Analyst Upgrades and Downgrades: AMD, Altria, Apple, BP, EA, Enphase, FireEye, Gilead, Mastercard, P&G, 2U and More

Stocks saw profit-taking on Tuesday, but the major indexes were up on Wednesday ahead of the Federal Reserve’s expected interest…

Jon C. Ogg | Jul 29, 2019 at 8:50 AM EDT

Top Analyst Upgrades and Downgrades: Aflac, Apple, Chipotle, Coca-Cola, Dell, Dish, Gilead, McDonald’s, Starbucks and More

The top analyst upgrades, downgrades and initiations seen on Monday included Aflac, Apple, Chipotle Mexican Grill, Coca-Cola, Dell Technologies, Dish…

Chris Lange | Jul 25, 2019 at 8:40 AM EDT

Major Biotechs See Rising Tide in Short Interest

The July 15 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Jul 15, 2019 at 3:29 PM EDT

Meet Gilead’s Newest Collaboration

Gilead and Galapagos each saw shares shoot up on Monday after the companies announced a new collaboration.

Jon C. Ogg | Jul 15, 2019 at 9:05 AM EDT

Top Analyst Upgrades and Downgrades: Agilent, Amazon, American Water Works, Crocs, Deere, GE, Gilead, Slack, Teva and More

The top analyst upgrades, downgrades and initiations on Monday included Agilent Technologies, Amazon.com, American Water Works, Crocs, Deere, General Electric,…

Chris Lange | Jul 11, 2019 at 9:50 AM EDT

Short Sellers Run for Cover From Major Biotechs

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The June 28 short interest data…

Jon C. Ogg | Jul 9, 2019 at 4:45 PM EDT

Many Top Pharma & Biotechs Rise as Drug Price Disclosure Thrown Out

President Trump lost ground with his efforts to force drug companies to list drug prices on TV ads, with the…

Chris Lange | Jun 26, 2019 at 10:05 AM EDT

Big Biotechs Scare Off Short Sellers

The June 14 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Jun 12, 2019 at 8:40 AM EDT

Big Biotechs Have Short Sellers on the Run

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The May 31 short interest data…

Jon C. Ogg | May 28, 2019 at 12:15 PM EDT

Goldman Sachs Crushes Value and Turnaround Hopes of Gilead Sciences

Goldman Sachs has muted any upside view by downgrading Gilead Sciences to Sell and lowering its price target.

1 … 11 12 13 14 15 … 49

Gilead Sciences : GILD

All Gilead Sciences Articles

Major Biotechs Scare Off Short Sellers

Short Sellers Hike Their Bets in Biotech

30 Sustainable Dividend Yields of 3.5% to Over 5% for Cautious Income Investors

Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead

Short Sellers Make a Move on Big Biotechs

Top Analyst Upgrades and Downgrades: AMD, Altria, Apple, BP, EA, Enphase, FireEye, Gilead, Mastercard, P&G, 2U and More

Top Analyst Upgrades and Downgrades: Aflac, Apple, Chipotle, Coca-Cola, Dell, Dish, Gilead, McDonald’s, Starbucks and More

Major Biotechs See Rising Tide in Short Interest

Meet Gilead’s Newest Collaboration

Top Analyst Upgrades and Downgrades: Agilent, Amazon, American Water Works, Crocs, Deere, GE, Gilead, Slack, Teva and More

Short Sellers Run for Cover From Major Biotechs

Many Top Pharma & Biotechs Rise as Drug Price Disclosure Thrown Out

Big Biotechs Scare Off Short Sellers

Big Biotechs Have Short Sellers on the Run

Goldman Sachs Crushes Value and Turnaround Hopes of Gilead Sciences

‘You’re Gonna Go Into Retirement Broke and Wait on Mom to Die’: Dave Ramsey’s Reality Check for a Caller Eyeing His Inheritance

“You Don’t Want to Pass the Burden of Investments Down to Your Daughter”: Suze Orman’s Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

EEM’s 0.69% Fee Quietly Costs You $690 a Year, but Your Cheaper Alternative Charges $90

'You're Gonna Go Into Retirement Broke and Wait on Mom to Die': Dave Ramsey's Reality Check for a Caller Eyeing His Inheritance

"You Don't Want to Pass the Burden of Investments Down to Your Daughter": Suze Orman's Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

‘You’re Gonna Go Into Retirement Broke and Wait on Mom to Die’: Dave Ramsey’s Reality Check for a Caller Eyeing His Inheritance

“You Don’t Want to Pass the Burden of Investments Down to Your Daughter”: Suze Orman’s Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

Gilead Sciences : GILD

All Gilead Sciences Articles

Major Biotechs Scare Off Short Sellers

Short Sellers Hike Their Bets in Biotech

30 Sustainable Dividend Yields of 3.5% to Over 5% for Cautious Income Investors

Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead

Short Sellers Make a Move on Big Biotechs

Top Analyst Upgrades and Downgrades: AMD, Altria, Apple, BP, EA, Enphase, FireEye, Gilead, Mastercard, P&G, 2U and More

Top Analyst Upgrades and Downgrades: Aflac, Apple, Chipotle, Coca-Cola, Dell, Dish, Gilead, McDonald’s, Starbucks and More

Major Biotechs See Rising Tide in Short Interest

Meet Gilead’s Newest Collaboration

Top Analyst Upgrades and Downgrades: Agilent, Amazon, American Water Works, Crocs, Deere, GE, Gilead, Slack, Teva and More

Short Sellers Run for Cover From Major Biotechs

Many Top Pharma & Biotechs Rise as Drug Price Disclosure Thrown Out

Big Biotechs Scare Off Short Sellers

Big Biotechs Have Short Sellers on the Run

Goldman Sachs Crushes Value and Turnaround Hopes of Gilead Sciences

‘You’re Gonna Go Into Retirement Broke and Wait on Mom to Die’: Dave Ramsey’s Reality Check for a Caller Eyeing His Inheritance

“You Don’t Want to Pass the Burden of Investments Down to Your Daughter”: Suze Orman’s Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

EEM’s 0.69% Fee Quietly Costs You $690 a Year, but Your Cheaper Alternative Charges $90

Featured Reads

'You're Gonna Go Into Retirement Broke and Wait on Mom to Die': Dave Ramsey's Reality Check for a Caller Eyeing His Inheritance

"You Don't Want to Pass the Burden of Investments Down to Your Daughter": Suze Orman's Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings